In a multimodal PET imaging approach, we determined the differential contribution of neurofibrillary tangles (measured with [F-18]AV-1451) and beta-amyloid burden (measured with [C-11]PiB) on degree of neurodegeneration (i.e., glucose metabolism measured with [F-18]FDG-PET) in patients with Alzheimer's disease. Across brain regions, we observed an interactive effect of beta-amyloid burden and tau deposition on glucose metabolism which was most pronounced in the parietal lobe. Elevated beta-amyloid burden was associated with a stronger influence of tau accumulation on glucose metabolism. Our data provide the first in vivo insights into the differential contribution of A and tau to neurodegeneration in Alzheimer's disease
A new piece to the puzzle:Contributions of in vivo Tau to Neurodegeneration in Alzheimer’s DiseaseGé...
Abstract The development of tau-specific positron emission tomography (PET) tracers allows imaging ...
Aims: Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especial...
Relationship of Tau Deposition and Hypometabolism in Alzheimer’s Disease: A Multimodal Imaging Appro...
The advent of the positron emission tomography tracer 18 F-AV1451 provides the unique opportunity to...
The clinical heterogeneity of Alzheimer's disease is not reflected in the rather diffuse cortical de...
Current Positron Emission Tomography (PET) biomarkers for Alzheimer’s disease (AD) assess either neu...
Posterior cortical hypometabolism measured with [ 18 F]-Fluorodeoxyglucose (FDG)-PET is a well-known...
BACKGROUND: The recent development of tau-specific positron emission tomography (PET) tracers has al...
Background: The recent development of tau-specific positron emission tomography (PET) tracers has al...
It has been suggested that glucose metabolism within the brain's default network is directly associa...
Purpose The present multimodal neuroimaging study examined whether amyloid pathology and glucose met...
The development of tau-specific positron emission tomography (PET) tracers allows imaging in vivo th...
The clinical heterogeneity of Alzheimer’s disease is not reflected in the rather diffuse cortical de...
International audienceAlzheimer's disease (AD), the most common age-related neurodegenerative disord...
A new piece to the puzzle:Contributions of in vivo Tau to Neurodegeneration in Alzheimer’s DiseaseGé...
Abstract The development of tau-specific positron emission tomography (PET) tracers allows imaging ...
Aims: Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especial...
Relationship of Tau Deposition and Hypometabolism in Alzheimer’s Disease: A Multimodal Imaging Appro...
The advent of the positron emission tomography tracer 18 F-AV1451 provides the unique opportunity to...
The clinical heterogeneity of Alzheimer's disease is not reflected in the rather diffuse cortical de...
Current Positron Emission Tomography (PET) biomarkers for Alzheimer’s disease (AD) assess either neu...
Posterior cortical hypometabolism measured with [ 18 F]-Fluorodeoxyglucose (FDG)-PET is a well-known...
BACKGROUND: The recent development of tau-specific positron emission tomography (PET) tracers has al...
Background: The recent development of tau-specific positron emission tomography (PET) tracers has al...
It has been suggested that glucose metabolism within the brain's default network is directly associa...
Purpose The present multimodal neuroimaging study examined whether amyloid pathology and glucose met...
The development of tau-specific positron emission tomography (PET) tracers allows imaging in vivo th...
The clinical heterogeneity of Alzheimer’s disease is not reflected in the rather diffuse cortical de...
International audienceAlzheimer's disease (AD), the most common age-related neurodegenerative disord...
A new piece to the puzzle:Contributions of in vivo Tau to Neurodegeneration in Alzheimer’s DiseaseGé...
Abstract The development of tau-specific positron emission tomography (PET) tracers allows imaging ...
Aims: Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especial...